Loading…

Platelet-rich plasma infusion as an adjunct treatment for persistent thin lining in frozen embryo transfer cycles: first US experience report

Purpose To study effect of intrauterine infusion of platelet-rich plasma (PRP) on endometrial growth in the setting of thin endometrial lining in patients with prior cancelled or failed frozen embryo transfer (FET) cycles. Materials and methods Single-arm cohort study of forty-six patients (51 cycle...

Full description

Saved in:
Bibliographic Details
Published in:Journal of assisted reproduction and genetics 2024-02, Vol.41 (2), p.483-491
Main Authors: Aghajanova, Lusine, Zhang, Amy, Lathi, Ruth B., Huddleston, Heather G.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c326t-16488813ad3898b9bfaef3d0ba2667197620a0c966a3730720b75c996c83eccd3
container_end_page 491
container_issue 2
container_start_page 483
container_title Journal of assisted reproduction and genetics
container_volume 41
creator Aghajanova, Lusine
Zhang, Amy
Lathi, Ruth B.
Huddleston, Heather G.
description Purpose To study effect of intrauterine infusion of platelet-rich plasma (PRP) on endometrial growth in the setting of thin endometrial lining in patients with prior cancelled or failed frozen embryo transfer (FET) cycles. Materials and methods Single-arm cohort study of forty-six patients (51 cycles) with endometrial lining thickness (EMT) < 6 mm in prior cancelled or failed FET cycles requesting intrauterine PRP treatment in upcoming FET cycle. The primary outcomes were final EMT in FET cycle and change in EMT after PRP. The secondary outcomes were overall pregnancy rate, clinical pregnancy rate, miscarriage rate, ongoing pregnancy, and live birth rates. Results The mean pre-PRP EMT in all FET cycles was 4.0 ± 1.1 mm, and mean post-PRP EMT (final) was 7.1 ± 1.0 mm. Of 51 cycles, 33 (64.7%) reached ≥ 7 mm after PRP administration. There was a significant difference between pre-PRP EMT and post-PRP EMT in all FET cycles, with mean difference of 3.0 ± 1.5 mm. Three cycles were cancelled for failure to reach adequate lining. Total pregnancy rate was 72.9% in our cohort of 48 cycles that proceeded to transfer. Clinical pregnancy rate was 54.2% (26/48 FET cycles); clinical miscarriage rate was 14.3% (5/35 pregnancies). Twenty six women had live birth (18 with EMT ≥ 7 mm and 8 with EMT < 7 mm). Response to PRP was not correlated with any pre-cycle characteristics. Conclusion We demonstrate a significant improvement in lining thickness and pregnancy rates in this challenging cohort of women after PRP infusion, with no adverse events. Cost-effectiveness of PRP with benefits and alternatives should be carefully considered.
doi_str_mv 10.1007/s10815-023-02993-8
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2893834022</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2931429019</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-16488813ad3898b9bfaef3d0ba2667197620a0c966a3730720b75c996c83eccd3</originalsourceid><addsrcrecordid>eNp9kc1u1TAQhSNERUvhBVggS2zYhI49-bHZoYo_qRJI0LXlOOPWV4kTbEfq5R36zrjcAhKLLmyPNd859uhU1QsObzhAf5Y4SN7WILAspbCWj6oT3vZY94jwuNTQyhqaTh5XT1PaAYCSAp9Ux9gr1bWNOqluv04m00S5jt5es3UyaTbMB7clvwRmEjNlH3dbsJnlSCbPFDJzS2QrxeRTvrvmax_Y5IMPV0XLXFx-UmA0D3G_FJUJyVFkdm8nSm-Z8zFldvmN0U3x8BQssUjrEvOz6siZKdHz-_O0uvzw_vv5p_riy8fP5-8uaouiyzXvGiklRzOiVHJQgzPkcITBiK7rueo7AQas6jqDPUIvYOhbW0a2EsnaEU-r1wffNS4_NkpZzz5ZmiYTaNmSFlKhxAaEKOir_9DdssVQfqeFQt4IBVwVShwoG5eUIjm9Rj-buNcc9F1Y-hCWLmHp32FpWUQv7623Yabxr-RPOgXAA5BKK1xR_Pf2A7a_AOUwoVE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2931429019</pqid></control><display><type>article</type><title>Platelet-rich plasma infusion as an adjunct treatment for persistent thin lining in frozen embryo transfer cycles: first US experience report</title><source>Springer Nature</source><creator>Aghajanova, Lusine ; Zhang, Amy ; Lathi, Ruth B. ; Huddleston, Heather G.</creator><creatorcontrib>Aghajanova, Lusine ; Zhang, Amy ; Lathi, Ruth B. ; Huddleston, Heather G.</creatorcontrib><description>Purpose To study effect of intrauterine infusion of platelet-rich plasma (PRP) on endometrial growth in the setting of thin endometrial lining in patients with prior cancelled or failed frozen embryo transfer (FET) cycles. Materials and methods Single-arm cohort study of forty-six patients (51 cycles) with endometrial lining thickness (EMT) &lt; 6 mm in prior cancelled or failed FET cycles requesting intrauterine PRP treatment in upcoming FET cycle. The primary outcomes were final EMT in FET cycle and change in EMT after PRP. The secondary outcomes were overall pregnancy rate, clinical pregnancy rate, miscarriage rate, ongoing pregnancy, and live birth rates. Results The mean pre-PRP EMT in all FET cycles was 4.0 ± 1.1 mm, and mean post-PRP EMT (final) was 7.1 ± 1.0 mm. Of 51 cycles, 33 (64.7%) reached ≥ 7 mm after PRP administration. There was a significant difference between pre-PRP EMT and post-PRP EMT in all FET cycles, with mean difference of 3.0 ± 1.5 mm. Three cycles were cancelled for failure to reach adequate lining. Total pregnancy rate was 72.9% in our cohort of 48 cycles that proceeded to transfer. Clinical pregnancy rate was 54.2% (26/48 FET cycles); clinical miscarriage rate was 14.3% (5/35 pregnancies). Twenty six women had live birth (18 with EMT ≥ 7 mm and 8 with EMT &lt; 7 mm). Response to PRP was not correlated with any pre-cycle characteristics. Conclusion We demonstrate a significant improvement in lining thickness and pregnancy rates in this challenging cohort of women after PRP infusion, with no adverse events. Cost-effectiveness of PRP with benefits and alternatives should be carefully considered.</description><identifier>ISSN: 1058-0468</identifier><identifier>EISSN: 1573-7330</identifier><identifier>DOI: 10.1007/s10815-023-02993-8</identifier><identifier>PMID: 37996549</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Abortion, Spontaneous - epidemiology ; Cohort Studies ; Embryo Transfer ; Endometrium ; Endometrium - physiology ; Female ; Gynecology ; Human Genetics ; Humans ; Medicine ; Medicine &amp; Public Health ; Miscarriage ; Patients ; Platelet-Rich Plasma ; Platelets ; Pregnancy ; Pregnancy Rate ; Reproductive Medicine ; Reproductive Physiology and Disease ; Retrospective Studies</subject><ispartof>Journal of assisted reproduction and genetics, 2024-02, Vol.41 (2), p.483-491</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-16488813ad3898b9bfaef3d0ba2667197620a0c966a3730720b75c996c83eccd3</cites><orcidid>0000-0002-3515-9252</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37996549$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aghajanova, Lusine</creatorcontrib><creatorcontrib>Zhang, Amy</creatorcontrib><creatorcontrib>Lathi, Ruth B.</creatorcontrib><creatorcontrib>Huddleston, Heather G.</creatorcontrib><title>Platelet-rich plasma infusion as an adjunct treatment for persistent thin lining in frozen embryo transfer cycles: first US experience report</title><title>Journal of assisted reproduction and genetics</title><addtitle>J Assist Reprod Genet</addtitle><addtitle>J Assist Reprod Genet</addtitle><description>Purpose To study effect of intrauterine infusion of platelet-rich plasma (PRP) on endometrial growth in the setting of thin endometrial lining in patients with prior cancelled or failed frozen embryo transfer (FET) cycles. Materials and methods Single-arm cohort study of forty-six patients (51 cycles) with endometrial lining thickness (EMT) &lt; 6 mm in prior cancelled or failed FET cycles requesting intrauterine PRP treatment in upcoming FET cycle. The primary outcomes were final EMT in FET cycle and change in EMT after PRP. The secondary outcomes were overall pregnancy rate, clinical pregnancy rate, miscarriage rate, ongoing pregnancy, and live birth rates. Results The mean pre-PRP EMT in all FET cycles was 4.0 ± 1.1 mm, and mean post-PRP EMT (final) was 7.1 ± 1.0 mm. Of 51 cycles, 33 (64.7%) reached ≥ 7 mm after PRP administration. There was a significant difference between pre-PRP EMT and post-PRP EMT in all FET cycles, with mean difference of 3.0 ± 1.5 mm. Three cycles were cancelled for failure to reach adequate lining. Total pregnancy rate was 72.9% in our cohort of 48 cycles that proceeded to transfer. Clinical pregnancy rate was 54.2% (26/48 FET cycles); clinical miscarriage rate was 14.3% (5/35 pregnancies). Twenty six women had live birth (18 with EMT ≥ 7 mm and 8 with EMT &lt; 7 mm). Response to PRP was not correlated with any pre-cycle characteristics. Conclusion We demonstrate a significant improvement in lining thickness and pregnancy rates in this challenging cohort of women after PRP infusion, with no adverse events. Cost-effectiveness of PRP with benefits and alternatives should be carefully considered.</description><subject>Abortion, Spontaneous - epidemiology</subject><subject>Cohort Studies</subject><subject>Embryo Transfer</subject><subject>Endometrium</subject><subject>Endometrium - physiology</subject><subject>Female</subject><subject>Gynecology</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Miscarriage</subject><subject>Patients</subject><subject>Platelet-Rich Plasma</subject><subject>Platelets</subject><subject>Pregnancy</subject><subject>Pregnancy Rate</subject><subject>Reproductive Medicine</subject><subject>Reproductive Physiology and Disease</subject><subject>Retrospective Studies</subject><issn>1058-0468</issn><issn>1573-7330</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1TAQhSNERUvhBVggS2zYhI49-bHZoYo_qRJI0LXlOOPWV4kTbEfq5R36zrjcAhKLLmyPNd859uhU1QsObzhAf5Y4SN7WILAspbCWj6oT3vZY94jwuNTQyhqaTh5XT1PaAYCSAp9Ux9gr1bWNOqluv04m00S5jt5es3UyaTbMB7clvwRmEjNlH3dbsJnlSCbPFDJzS2QrxeRTvrvmax_Y5IMPV0XLXFx-UmA0D3G_FJUJyVFkdm8nSm-Z8zFldvmN0U3x8BQssUjrEvOz6siZKdHz-_O0uvzw_vv5p_riy8fP5-8uaouiyzXvGiklRzOiVHJQgzPkcITBiK7rueo7AQas6jqDPUIvYOhbW0a2EsnaEU-r1wffNS4_NkpZzz5ZmiYTaNmSFlKhxAaEKOir_9DdssVQfqeFQt4IBVwVShwoG5eUIjm9Rj-buNcc9F1Y-hCWLmHp32FpWUQv7623Yabxr-RPOgXAA5BKK1xR_Pf2A7a_AOUwoVE</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Aghajanova, Lusine</creator><creator>Zhang, Amy</creator><creator>Lathi, Ruth B.</creator><creator>Huddleston, Heather G.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3515-9252</orcidid></search><sort><creationdate>20240201</creationdate><title>Platelet-rich plasma infusion as an adjunct treatment for persistent thin lining in frozen embryo transfer cycles: first US experience report</title><author>Aghajanova, Lusine ; Zhang, Amy ; Lathi, Ruth B. ; Huddleston, Heather G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-16488813ad3898b9bfaef3d0ba2667197620a0c966a3730720b75c996c83eccd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Abortion, Spontaneous - epidemiology</topic><topic>Cohort Studies</topic><topic>Embryo Transfer</topic><topic>Endometrium</topic><topic>Endometrium - physiology</topic><topic>Female</topic><topic>Gynecology</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Miscarriage</topic><topic>Patients</topic><topic>Platelet-Rich Plasma</topic><topic>Platelets</topic><topic>Pregnancy</topic><topic>Pregnancy Rate</topic><topic>Reproductive Medicine</topic><topic>Reproductive Physiology and Disease</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aghajanova, Lusine</creatorcontrib><creatorcontrib>Zhang, Amy</creatorcontrib><creatorcontrib>Lathi, Ruth B.</creatorcontrib><creatorcontrib>Huddleston, Heather G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of assisted reproduction and genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aghajanova, Lusine</au><au>Zhang, Amy</au><au>Lathi, Ruth B.</au><au>Huddleston, Heather G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Platelet-rich plasma infusion as an adjunct treatment for persistent thin lining in frozen embryo transfer cycles: first US experience report</atitle><jtitle>Journal of assisted reproduction and genetics</jtitle><stitle>J Assist Reprod Genet</stitle><addtitle>J Assist Reprod Genet</addtitle><date>2024-02-01</date><risdate>2024</risdate><volume>41</volume><issue>2</issue><spage>483</spage><epage>491</epage><pages>483-491</pages><issn>1058-0468</issn><eissn>1573-7330</eissn><abstract>Purpose To study effect of intrauterine infusion of platelet-rich plasma (PRP) on endometrial growth in the setting of thin endometrial lining in patients with prior cancelled or failed frozen embryo transfer (FET) cycles. Materials and methods Single-arm cohort study of forty-six patients (51 cycles) with endometrial lining thickness (EMT) &lt; 6 mm in prior cancelled or failed FET cycles requesting intrauterine PRP treatment in upcoming FET cycle. The primary outcomes were final EMT in FET cycle and change in EMT after PRP. The secondary outcomes were overall pregnancy rate, clinical pregnancy rate, miscarriage rate, ongoing pregnancy, and live birth rates. Results The mean pre-PRP EMT in all FET cycles was 4.0 ± 1.1 mm, and mean post-PRP EMT (final) was 7.1 ± 1.0 mm. Of 51 cycles, 33 (64.7%) reached ≥ 7 mm after PRP administration. There was a significant difference between pre-PRP EMT and post-PRP EMT in all FET cycles, with mean difference of 3.0 ± 1.5 mm. Three cycles were cancelled for failure to reach adequate lining. Total pregnancy rate was 72.9% in our cohort of 48 cycles that proceeded to transfer. Clinical pregnancy rate was 54.2% (26/48 FET cycles); clinical miscarriage rate was 14.3% (5/35 pregnancies). Twenty six women had live birth (18 with EMT ≥ 7 mm and 8 with EMT &lt; 7 mm). Response to PRP was not correlated with any pre-cycle characteristics. Conclusion We demonstrate a significant improvement in lining thickness and pregnancy rates in this challenging cohort of women after PRP infusion, with no adverse events. Cost-effectiveness of PRP with benefits and alternatives should be carefully considered.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>37996549</pmid><doi>10.1007/s10815-023-02993-8</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-3515-9252</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1058-0468
ispartof Journal of assisted reproduction and genetics, 2024-02, Vol.41 (2), p.483-491
issn 1058-0468
1573-7330
language eng
recordid cdi_proquest_miscellaneous_2893834022
source Springer Nature
subjects Abortion, Spontaneous - epidemiology
Cohort Studies
Embryo Transfer
Endometrium
Endometrium - physiology
Female
Gynecology
Human Genetics
Humans
Medicine
Medicine & Public Health
Miscarriage
Patients
Platelet-Rich Plasma
Platelets
Pregnancy
Pregnancy Rate
Reproductive Medicine
Reproductive Physiology and Disease
Retrospective Studies
title Platelet-rich plasma infusion as an adjunct treatment for persistent thin lining in frozen embryo transfer cycles: first US experience report
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T19%3A32%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Platelet-rich%20plasma%20infusion%20as%20an%20adjunct%20treatment%20for%20persistent%20thin%20lining%20in%20frozen%20embryo%20transfer%20cycles:%20first%20US%20experience%20report&rft.jtitle=Journal%20of%20assisted%20reproduction%20and%20genetics&rft.au=Aghajanova,%20Lusine&rft.date=2024-02-01&rft.volume=41&rft.issue=2&rft.spage=483&rft.epage=491&rft.pages=483-491&rft.issn=1058-0468&rft.eissn=1573-7330&rft_id=info:doi/10.1007/s10815-023-02993-8&rft_dat=%3Cproquest_cross%3E2931429019%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c326t-16488813ad3898b9bfaef3d0ba2667197620a0c966a3730720b75c996c83eccd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2931429019&rft_id=info:pmid/37996549&rfr_iscdi=true